CANY
OGN icon

Caxton Associates (New York)’s Organon & Co OGN Stock Holding History

Caxton Associates (New York)’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,912
Closed -$438K – 620
2024
Q3 		$438K Buy
+22,912
New +$475K 0.02% 382
2024
Q2 		– Sell
-27,203
Closed -$511K – 562
2024
Q1 		$511K Buy
+27,203
New +$467K 0.03% 316

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caxton Associates (New York)'s OGN Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 22,912 shares — an estimated $438K sold.

Caxton Associates (New York) first reported a position in OGN in Q1 2024 and held it in 2 quarters. The position peaked at $511K in Q1 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 22,912 Organon & Co shares in Q4 2024, an estimated $438K.
  • Caxton Associates (New York) first reported a position in Organon & Co in Q1 2024 and held it in 2 quarters.
  • Caxton Associates (New York)'s Organon & Co position peaked at $511K in Q1 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.